Therapy Individualization for Atopic Dermatitis

The expert panel discusses the heterogeneity of atopic dermatitis manifestation and therapy decisions for individual patients.

Related Videos
Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion
Berdazimer Gel Provides Complete Molluscum Clearance in 30% of Patients in 12 Weeks
Ester Del Duca, MD: Molecular Phenotype Differences in African Eczema Patients
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
Related Content

Positive Results for Ivarmacitinib in Treating Patients with Atopic Dermatitis

March 21st 2023

Advances in Pediatric Eczema Highlight 2022

December 21st 2022

Orismilast Tablets Significantly Clear Psoriasis Skin

March 20th 2023

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

July 12th 2022

Izokibep Potentially Clears Hidradenitis Suppurativa Lesions at 12 Weeks

March 20th 2023

Baricitinib Maintains Alopecia Hair Regrowth at 2 Years

March 19th 2023

Positive Results for Ivarmacitinib in Treating Patients with Atopic Dermatitis

March 21st 2023

Advances in Pediatric Eczema Highlight 2022

December 21st 2022

Orismilast Tablets Significantly Clear Psoriasis Skin

March 20th 2023

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

July 12th 2022

Izokibep Potentially Clears Hidradenitis Suppurativa Lesions at 12 Weeks

March 20th 2023

Baricitinib Maintains Alopecia Hair Regrowth at 2 Years

March 19th 2023

Positive Results for Ivarmacitinib in Treating Patients with Atopic Dermatitis

March 21st 2023

Advances in Pediatric Eczema Highlight 2022

December 21st 2022

Orismilast Tablets Significantly Clear Psoriasis Skin

March 20th 2023

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

July 12th 2022

Izokibep Potentially Clears Hidradenitis Suppurativa Lesions at 12 Weeks

March 20th 2023

Baricitinib Maintains Alopecia Hair Regrowth at 2 Years

March 19th 2023
© 2023 MJH Life Sciences

All rights reserved.